Pasithea Therapeutics (KTTA) Research & Development (2022 - 2026)
Pasithea Therapeutics (KTTA) recorded Research & Development of $3.69 million in Q2 2026, up 71.5% from $2.15 million a year earlier and up 25.3% from the prior quarter.
Powered by 
Analysis
Pasithea Therapeutics (KTTA) Research & Development (2022 - 2026) Analysis & Trends
On a TTM basis, Pasithea Therapeutics' Research & Development came in at $10.73 million as of Jun 30, 2026, up 54.0% year-over-year; for FY2025, it was $7.98 million, up 10.9% from FY2024.
- Annual Research & Development has a three-year compound annual growth rate of 44.1% (FY2022 to FY2025).
- Across earlier years, Research & Development came in at $7.2 million in FY2024 (-11.1%), $8.1 million in FY2023 (+203.9%) and $2.67 million in FY2022.
- The Q2 2026 figure is the highest quarterly Research & Development in data going back to Q4 2022.
- On a year-over-year basis, Research & Development has increased for three consecutive quarters, with growth averaging 17.7% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 141.7% in Q4 2023, against a decline of 54.9% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.94 million (Q1 2026), $2.74 million (Q4 2025) and $1.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Pasithea Therapeutics | 15.54 Mn | -139.85 Mn | - | 3.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.69 Mn |
| Mar 31, 2026 | 2.94 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 2.15 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 2.36 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Dec 31, 2023 | 3.35 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 1.39 Mn |
API Access
Pasithea Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=KTTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "KTTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=KTTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();